Shanghai Orsin Medical Technology Co., Ltd. miaomiao8615@orsins.com 86-021-57450666
Detalles del producto
Lugar de origen: Porcelana
Nombre de la marca: Orsin
Certificación: ISO 13485
Número de modelo: Activador de coágulos de gel
Pago y términos de envío
Cantidad de orden mínima: 100/pcs
Precio: Negociable
Tiempo de entrega: 1-4 semanas
Condiciones de pago: L/C, D/A, D/P, T/T, Western Union
Capacidad de la fuente: 20 millones/pcs/polilla
Solicitud: |
Prueba de laboratorio clínico |
Material de cierre: |
Tope de goma sintético |
Material de embalaje: |
Vaso |
Tipo de tubo: |
Dolor |
Uso clínico: |
Banco de sangre |
Ventajas: |
Alto rendimiento de recuperación |
Rasgo: |
Cáncer |
Pedidos de lotes mixtos: |
Compatible |
Estéril: |
No estéril |
Tubo especializado: |
Tubo activador de coágulos |
Color: |
Transparente |
Solicitud: |
Prueba de laboratorio clínico |
Material de cierre: |
Tope de goma sintético |
Material de embalaje: |
Vaso |
Tipo de tubo: |
Dolor |
Uso clínico: |
Banco de sangre |
Ventajas: |
Alto rendimiento de recuperación |
Rasgo: |
Cáncer |
Pedidos de lotes mixtos: |
Compatible |
Estéril: |
No estéril |
Tubo especializado: |
Tubo activador de coágulos |
Color: |
Transparente |
Key Features
Highly Efficient Clotting Initiation: Contains high-purity, specific concentrations of clot activators (e.g., Silica, Kaolin, Ellagic Acid, Snake Venom Enzymes, depending on the type) to rapidly and reliably initiate the coagulation cascade, significantly reducing clotting test times.
Excellent Sample Stability: Incorporates an inert gel barrier that forms a stable physical seal after centrifugation, effectively separating serum/plasma from blood cells. This prevents cellular metabolite interference and ensures result accuracy over an extended period.
Pre-filled & Ready-to-Use: Typically supplied in pre-evacuated blood collection tubes, enabling immediate use upon opening. Simplifies workflow, minimizes manual errors, and enhances laboratory efficiency.
High Lot-to-Lot Consistency: Rigorous manufacturing processes and quality control ensure consistent performance across different production lots, guaranteeing reliable and comparable test results.
Broad Compatibility: Suitable for use with a wide range of automated coagulation analyzers and manual testing methods, catering to diverse laboratory requirements.
Basic Parameters
Activator Type: Silica / Kaolin / Ellagic Acid / Snake Venom Enzymes / etc. (Specific type depends on product variant).
Tube Size: Common sizes: 1ml-10ml(Contains micro tubes)
Draw Volume: Requires precise blood draw to the tube's fill line (e.g., 1.8mL, 2.7mL).
Additive Concentration: Precisely optimized concentration of activator for optimal clotting initiation.
Inert Gel: Positioned at the bottom, forms a stable barrier after centrifugation.
Mixing: Tubes must be gently inverted 5-10 times immediately after blood draw to ensure thorough mixing with activator/anticoagulant.
Storage Conditions: Room Temperature (15-30°C). Protect from freezing, excessive heat, and direct sunlight.
Shelf Life: Refer to product outer packaging label (Typically 12-24 months).
Intended Use: Primarily used for venous blood collection, anticoagulation, and clot activation in clinical laboratories for coagulation tests such as Prothrombin Time (PT), Activated Partial Thromboplastin Time (APTT), Thrombin Time (TT), and Fibrinogen (FIB) assays.
Parameter Category |
Detailed Specifications |
---|---|
Dimensions |
Tube diameter × length: Ø13×75mm, Ø13×100mm, Ø16×100mm |
Material |
Glass or PET plastic (silicone-coated interior to reduce cell adhesion) |
Draw Volume |
1ml/2ml/3ml/4ml/5ml/6ml/9ml/10ml (precise filling to marked line required) |
Mixing Protocol |
Gently invert tube 5-10 times immediately after blood draw |
Clotting & Centrifugation |
Clotting time: 15-30 min (ambient temperature ≥16°C); |
Storage Conditions |
4°C–25°C, protected from light; freezing prohibited |
Shelf Life |
1 year (12-24 months for some brands) |
Test Category |
Specific Applications |
Clinical Significance & Precautions |
---|---|---|
Biochemistry |
Liver/kidney function, electrolytes, cardiac enzymes (e.g., lithium, ceruloplasmin), lipid metabolism |
Basic health screening; avoid hemolysis interference |
Immunoassays |
Tumor markers: AFP/PSA/CEA/CA125/CA19-9; |
High-sensitivity testing; gel barrier minimizes cellular metabolite interference |
Serology/Virology |
HIV/HBV (HBsAg)/HCV antibodies, Rubella/Toxoplasma gondii/Dengue antibodies, autoantibodies (ANA/dsDNA) |
Avoid repeated freeze-thaw cycles; serum remains stable for 48h post-separation |
Separation Gel Advantages:
Japanese-imported gel with precise density (between serum and blood cells) forms solid barrier post-centrifugation, blocking molecular exchange (>48h serum stability).
Temperature-resistant (up to 45°C) and gamma-irradiated for sterilization; resistant to degradation during transport.
Limitations for Drug/Hormone Testing:
Potential concentration deviations due to diffusion of small-molecule drugs/hormones into gel layer; tube compatibility verification recommended.
Operational Protocols:
Immediate mixing after blood draw is critical for uniform activator contact;
Low-temperature environments (<16°C) require extended clotting time or increased activator concentration.
Question |
Answer & Solution |
---|---|
1. Fuzzy separation/milky serum after centrifugation? |
Cause: Incomplete clotting or incorrect centrifugation parameters. |
2. Gel layer floating or sinking? |
Cause: High temperature (>45°C) or gel-sample density mismatch. |
3. Prolonged clotting time (>30 min)? |
Cause: Low ambient temperature or expired activator. |
4. Underestimated drug concentrations? |
⚠️ Critical Alert: Small-molecule drugs (e.g., warfarin, antibiotics) may diffuse into gel! |
5. Suitable for coagulation tests (PT/APTT)? |
❌ Prohibited: Activators interfere with clotting factors! |
6. Stability period of separated serum? |
Stability: |
7. Risks of delayed mixing post-draw? |
Risk: Incomplete activation → fibrin formation → probe clogging! |
NEVER FREEZE: Gel permanently degrades upon freezing!
AVOID >30°C: Accelerates activator degradation during storage/transport.
Pre-centrifugation check: Incomplete clotting causes cellular contamination!
Post-centrifugation: Wait 10 minutes before opening to stabilize gel barrier.